All investors

Norwest is a multi-stage, sector-diverse investment firm that backs companies from Seed through Growth, with strongest pattern recognition in enterprise software, consumer, and healthcare. The firm combines high-conviction early investing in exceptional teams with disciplined later-stage underwriting around efficient growth, customer love, and paths to profitability.

Evaluation weights

How much weight this investor places on each dimension. Totals 100%.

Team-led · 33%
Metrics
16%

Revenue, growth, and unit economics

Market
27%

Size, timing, and competitive landscape

Team
33%

Founder experience and execution ability

Product
24%

Differentiation and technical quality

  • Bias toward founder quality over perfect early metrics
  • Comfort with early risk if team and market insight are exceptional
  • Strong preference for efficient growth over vanity growth
  • Favors businesses that can pair product love with disciplined scaling

Pitch difficulty

How hard it is to get a meeting and close funding from this investor.

Funded / yr
30

Deals closed in a typical year.

Led / yr
18

Rounds led in the last 12 months.

Pitches / yr
~1450

Decks reviewed in a typical year.

Acceptance rate
2.1%

Share of pitches that get funded.

Estimated — public data is not fully disclosed.

Why it's hard
  • High emphasis on founder-market fit and execution quality
  • Requires concrete evidence of customer love or unusually strong pre-launch insight
  • Penalizes weak differentiation and shallow competitive understanding
  • Applies disciplined scrutiny to unit economics and profitability path in later stages

Norwest is broad in stage coverage and can invest before launch, but it maintains a high bar on founder quality, customer love, differentiation, and operating discipline. Its flexibility on timing does not translate into looseness on judgment; the firm is willing to move early, yet only when conviction is strong across team, product, and market.

Green flags

What drives a yes for this investor.

  • Exceptional founder-market fit with humility, insight, and execution ability
  • Clear customer love shown through retention, engagement, NPS, or strong qualitative pull
  • Thoughtful, iterative product development informed by customer testing
  • Large or expanding market with credible differentiation
  • Disciplined go-to-market and unit economics, especially as the business scales

Red flags

What kills deals and gets a fast no.

  • Weak evidence that users truly care about the product
  • Inability to explain differentiation or competitive dynamics clearly
  • Sloppy thinking on CAC, payback, LTV:CAC, or scaling efficiency
  • Growth-at-all-costs plans with no credible path to profitability
  • Founders who appear uncoachable or disconnected from customer needs

How to win

Patterns that lead to successful pitches.

  • Lead with why this team has unique insight and right to win
  • Show real customer love using retention, engagement, NPS, or strong qualitative evidence
  • Demonstrate rapid learning loops and product iteration based on customer feedback
  • Present a sharp view of market structure, competitors, and differentiation
  • For scaling companies, show efficient GTM with credible CAC payback and profitability trajectory

Fund strategy & identity

Who they are and how they operate.

  • Invest across the full company lifecycle from Seed/Series A to Growth
  • Lead or co-lead rounds where conviction is high
  • Back strong teams even before launch when market insight is exceptional
  • Use flexible underwriting rather than rigid metric cutoffs at early stage
  • Scale capital meaningfully behind winners, from venture checks to large growth rounds
Firm identity
Multi-stage investor spanning venture and growth equity Generalist with deep strength in enterprise/B2B SaaS, consumer, and healthcare High-conviction on founder-market fit and team quality Operationally disciplined, especially on go-to-market efficiency Global platform with concentration in North America, India, and Israel

Investment focus

Industries, themes, and typical ARR expectations.

Industries
Enterprise softwareB2B SaaSConsumerHealthcare ITLife sciencesData and analyticsMarketplaces
Investment themes
Enterprise software and B2B SaaS category creatorsHealthcare IT, data, and life sciences innovationConsumer brands and marketplaces with efficient scalingData platforms and analytics businesses with durable retentionVertical software and operational workflow platformsCapital-efficient growth equity opportunities with strategic M&A potential
Typical check by stage
Seed$1M-$5M
Series A$5M-$15M
Series B$10M-$25M
Series C$15M-$30M
Growth$20M-$200M
Typical ARR by stage
Seed$0-$1M
Series A$1M-$3M
Series B$5M-$20M
Series C$20M-$50M
Growth$50M+ revenue

Investment thesis

Core beliefs and strategy behind their investing approach.

Norwest is a generalist, multi‑stage investor focused on enterprise/technology (including B2B SaaS), consumer, and healthcare/life‑sciences sectors. Its thesis is that enduring value is created by pairing strong founders with large, expanding markets and operational discipline. The firm invests globally but concentrates on North America, India, and Israel, leveraging local offices. It pursues the full capital continuum—from seed relationships and product validation to Series A/B scaling and later growth equity—deploying $1‑30 M in venture checks and $20‑200 M in growth equity. Norwest avoids rigid metric thresholds, instead looking for concrete evidence of customer love, iterative product development, and scalable unit economics. In growth equity it prioritises efficient growth (reasonable CAC payback, strong LTV:CAC) and paths to profitability.

Decision patterns

How they evaluate and make investment decisions.

Norwest repeatedly frames evaluation along three vectors—people, product, and market—with pronounced weight on founder‑market fit (“the best teams win”). It will invest at Series A even “well before the product launched” when it has conviction in the team’s insights, humility, customer empathy, and ability to execute. Signals that move Norwest to a “yes” at seed‑A include customers loving the product (strong NPS, retention, engagement), evidence the team listens and iterates quickly based on structured tests, and clear thinking about where/how to find customers (even if CACs aren’t fully known yet). Deal‑breakers are the inverse: weak or untested customer love; inability to articulate differentiation; superficial grasp of competitive dynamics; or poor/undisciplined unit‑economics thinking. In growth equity, Norwest stresses efficient top‑line growth, reasonable CAC payback, and healthy LTV:CAC, flagging “growth at all costs” without a path to profitability as a negative.

Risk appetite

Norwest is a high‑conviction but disciplined investor. It is comfortable leading or co‑leading early‑stage rounds and will back pre‑revenue or pre‑launch companies when the team, market opportunity, and differentiation are clear. In growth equity it prefers businesses with proven product‑market fit, efficient growth, and credible profitability, emphasizing CAC payback under 24 months (ideally under 12) and LTV:CAC of at least 2× (ideally 3×+). This reflects a moderate‑to‑aggressive risk posture: willing to take early technical/market risk on outstanding teams while insisting on disciplined go‑to‑market and unit‑economics as companies scale.

Notable investments

Key portfolio companies and why they fit the thesis.

  • UdemyLead
    Global marketplace and ed‑tech platform at scale; aligns with Norwest’s consumer/marketplaces and software thesis.
  • ExabeamLead
    Security analytics/SIEM innovation squarely in enterprise software/security; Norwest led the Series A.
  • TalkspaceLead
    Digital health/tele‑therapy in a large market; Norwest led the Series B.
  • QualifiedLead
    Salesforce‑ecosystem conversational marketing for B2B SaaS; Norwest led the Series A.
  • EdiphiLead
    Construction‑tech estimating SaaS modernizing pre‑construction workflows; Norwest led the Series A.
  • GongLead
    Category‑creating revenue‑intelligence platform (enterprise SaaS/AI); Norwest led Seed and A1.
  • SpiffLead
    Next‑gen commissions‑management SaaS for mid‑market/enterprise; Norwest led the Series A.
  • ReplicantLead
    Voice‑AI contact‑center automation fitting Norwest’s enterprise/AI thesis; Norwest led Seed and Series A.
  • Red AccessLead
    Agentless browser/SSE security solution core to Norwest’s Israel/enterprise security focus; Norwest led the Series A.

Key people

Partners who lead investments and shape the thesis.

  • JC
    Jeff Crowe
    Senior Managing Partner
    Multi‑stage investingFirm leadership
  • JK
    Jon Kossow
    Managing Partner
    Multi‑stage investingGrowth equity co‑lead
  • SB
    Sonya Brown
    General Partner, Co‑Head of Growth Equity
    Growth equityConsumer, internet, education, business services
  • RD
    Ran Ding
    General Partner, Co‑Head of Growth Equity
    Growth equityTechnology, business services, consumer
  • DZ
    Dave Zilberman
    General Partner
    Early‑to‑late‑stage enterpriseInfrastructure

Public voice

Notable statements and public positions.

  • “We take pride in squinting our eyes and seeing the potential.” — Matt Howard, How to Ace Your Series A Fundraise.
  • “Tactically speaking, we evaluate companies along three vectors: people, product, and market… On people: The best teams win.” — Matt Howard, How to Ace Your Series A Fundraise.
  • “At Norwest we developed a new internal metric, ‘3GP’ (3 × revenue growth + profitability), which we believe better captures the value trade‑off between growth and profitability.” — Ran Ding, Keeping it 100: A Better Way of Assessing SaaS Performance than ‘Rule of 40’.